Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

ERK1/2 regulation of CD44 modulates oral cancer aggressiveness.

ERK1/2 regulation of CD44 modulates oral cancer aggressiveness. Cancer Res. 2012 Jan 01; 72(1):365-74.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.